期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 18, 期 22, 页码 5864-5866出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2008.06.015
关键词
Carcinogen; CYP1A1 isozyme; Cytochrome P450; Dioxin; Fluorogenic substrate; Prodrug; Resveratrol; Rhodamine 110; Trimethyl lock
资金
- NIH [CA073808]
- NMR-FAM [P41 RR02301]
- Biotechnology Training Grant [08349]
- ACS Division of Organic Chemistry Graduate Fellowship
- Genentech Foundation.
A derivative of rhodamine 110 has been designed and assessed as a probe for cytochrome P450 activity. This probe is the first to utilize a 'trimethyl lock' that is triggered by cleavage of an ether bond. In vitro, fluorescence was manifested by the CYP1A1 isozyme with k(cat)/K-M = 8.8 x 10(3) M (1) s (1) and K-M = 0.09 mu M. In cellulo, the probe revealed the induction of cytochrome P450 activity by the carcinogen 2,3,7,8-tetrachlorodibenzo-p- dioxin, and its repression by the chemoprotectant resveratrol. (C) 2008 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据